<p>ABLE Financial Group LLC 在第三季度購買了 CVS Health Corporation (NYSE:CVS - 免費報告) 的新股份，根據其最近向證券交易委員會提交的 13F 文件。該基金購買了 41,227 股該藥房運營商的股票，價值約為 3,108,000 美元。</p>
<ul>
<li>CVS Health 收益增長，股息保持強勁</li>
</ul>
<p>其他機構投資者和對沖基金也對該公司的持股進行了調整。Avion Wealth 在第二季度將其在 CVS Health 的持股增加了 99.0%。Avion Wealth 目前擁有 380 股該藥房運營商的股票，價值 26,000 美元，在此期間又購買了 189 股。Harbor Asset Planning Inc. 在第二季度獲得了 CVS Health 的新股份，價值約為 30,000 美元。Bell Investment Advisors Inc 在第一季度將其在 CVS Health 的持股增加了 119.8%。Bell Investment Advisors Inc 目前擁有 455 股該藥房運營商的股票，價值 31,000 美元，在上個季度又購買了 248 股。Front Row Advisors LLC 在第二季度將其在 CVS Health 的持股增加了 436.5%。Front Row Advisors LLC 目前擁有 456 股該藥房運營商的股票，價值 31,000 美元，在上個季度又購買了 371 股。最後，Roxbury Financial LLC 在第二季度將其在 CVS Health 的持股增加了 78.3%。Roxbury Financial LLC 目前擁有 460 股該藥房運營商的股票，價值 32,000 美元，在此期間又購買了 202 股。當前 80.66% 的股票由機構投資者和對沖基金持有。</p>
<h2>分析師評級變動</h2>
<p>多家券商最近對 CVS 發佈了報告。高盛集團將 CVS Health 的目標價從 93.00 美元上調至 95.00 美元，並在 12 月 10 日的報告中給予該股票 &#34;買入&#34; 評級。Truist Financial 在 12 月 10 日的研究報告中設定了 CVS Health 的目標價為 100.00 美元。Wolfe Research 在 12 月 8 日的研究報告中將 CVS Health 的目標價從 85.00 美元上調至 100.00 美元，並給予公司 &#34;跑贏大盤&#34; 評級。Jefferies Financial Group 在 10 月 30 日的報告中將 CVS Health 的目標價從 92.00 美元上調至 98.00 美元。最後，Zacks Research 在 9 月 8 日的研究報告中將 CVS Health 的評級從 &#34;強力買入&#34; 下調至 &#34;持有&#34;。兩位投資分析師對該股票給予了強力買入評級，二十位給予了買入評級，四位給予了持有評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 &#34;適度買入&#34;，共識目標價為 94.67 美元。</p>
<ul>
<li>MarketBeat 週迴顧 – 05/12 - 05/16</li>
</ul>
<p><strong>查看我們最新的 CVS 股票分析</strong></p>
<h2>CVS Health 股票表現</h2>
<p>CVS 的股票在週五開盤價為 77.70 美元。CVS Health Corporation 的 12 個月低點為 43.56 美元，12 個月高點為 85.15 美元。該股票的市值為 986.3 億美元，市盈率為 204.47，市盈增長比率為 0.77，貝塔係數為 0.48。該公司的 50 日移動平均線為 79.09 美元，200 日移動平均線為 72.43 美元。該公司的債務與股本比率為 0.83，流動比率為 0.83，速動比率為 0.63。</p>
<ul>
<li>現在是購買諾和諾德股票的好時機嗎？</li>
</ul>
<p>CVS Health (NYSE:CVS - 獲取免費報告) 最近在 10 月 29 日發佈了其財報。該藥房運營商報告本季度每股收益為 1.60 美元，超過分析師一致預期的 1.36 美元，超出 0.24 美元。該公司本季度的收入為 1,028.7 億美元，而分析師預期為 988.5 億美元。CVS Health 的淨利潤率為 0.12%，股本回報率為 11.45%。該公司本季度的收入同比增長 7.8%。去年同期，該公司每股收益為 1.09 美元。CVS Health 已將其 2025 財年的指導目標設定為 6.550-6.650 每股收益。股票研究分析師預計 CVS Health Corporation 本財年將發佈 5.89 每股收益。</p>
<h2>CVS Health 公司簡介</h2>
<p>(免費報告)</p>
<p>CVS Health Corporation 是一家多元化的醫療保健公司，運營着一個大型零售藥房網絡、藥房福利管理服務和醫療保健解決方案。公司總部位於羅德島州的伍恩索克特，追溯其根源至 1960 年代初期，已發展成為一個綜合的處方藥、非處方產品、臨牀服務和健康保險產品的提供者。其運營模式結合了零售藥房和店內診所以及更廣泛的藥房和健康計劃能力。</p>
<p>主要業務活動包括 CVS 藥房零售運營、MinuteClinic 診所和提供擴展臨牀服務的 HealthHUB 位置。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們更看好的股票超過 CVS Health</li>
<li>精通紀律：克服交易中的情緒挑戰</li>
<li>這三家銀行在年末反彈，但這種趨勢會持續嗎？</li>
<li>如何知道一隻股票是否支付股息以及何時支付</li>
<li>三隻飆升的股票剛剛獲得標準普爾 500 的最終批准</li>
<li>如何計算投資回報率 (ROI)</li>
<li>該 ETF 在美聯儲降息後獲得了重大順風</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1,000 美元在 CVS Health 嗎？</h2>
<p>在考慮 CVS Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 CVS Health 並不在名單上。</p>
<p>雖然 CVS Health 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

西維斯

<p>ABLE Financial Group LLC 在第三季度收購了 41,227 股 CVS Health Corporation 的股票，價值約為 3,108,000 美元。此交易已在他們最新的 13F 文件中向 SEC 報告。CVS Health 的股票主要由機構投資者持有，擁有比例為 80.66%。分析師對該股票給予了 “適度買入” 的共識評級，目標價為 94.67 美元。CVS Health 報告了強勁的收益，年同比收入增長 7.8%，並將其 2025 財年的每股收益指導定在 6.550-6.650</p>

<p>ABLE Financial Group LLC bought a new stake in CVS Health Corporation (NYSE:CVS - Free Report) in the third quarter, according to its most recent 13F filing with the Securities &amp; Exchange Commission. The fund bought 41,227 shares of the pharmacy operator's stock, valued at approximately $3,108,000.</p>
<div class="lb-trans"><p>ABLE Financial Group LLC 在第三季度購買了 CVS Health Corporation (NYSE:CVS - 免費報告) 的新股份，根據其最近向證券交易委員會提交的 13F 文件。該基金購買了 41,227 股該藥房運營商的股票，價值約為 3,108,000 美元。</p>
</div><ul>
<li>CVS Health Gains as Revenue Grows, Dividend Remains Strong</li>
</ul>
<div class="lb-trans"><ul>
<li>CVS Health 收益增長，股息保持強勁</li>
</ul>
</div><p>Other institutional investors and hedge funds have also made changes to their positions in the company. Avion Wealth increased its position in CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator's stock worth $26,000 after buying an additional 189 shares during the period. Harbor Asset Planning Inc. acquired a new stake in shares of CVS Health in the 2nd quarter worth about $30,000. Bell Investment Advisors Inc lifted its position in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator's stock valued at $31,000 after purchasing an additional 248 shares during the last quarter. Front Row Advisors LLC grew its position in CVS Health by 436.5% in the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator's stock worth $31,000 after purchasing an additional 371 shares during the last quarter. Finally, Roxbury Financial LLC increased its stake in shares of CVS Health by 78.3% in the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator's stock valued at $32,000 after purchasing an additional 202 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他機構投資者和對沖基金也對該公司的持股進行了調整。Avion Wealth 在第二季度將其在 CVS Health 的持股增加了 99.0%。Avion Wealth 目前擁有 380 股該藥房運營商的股票，價值 26,000 美元，在此期間又購買了 189 股。Harbor Asset Planning Inc. 在第二季度獲得了 CVS Health 的新股份，價值約為 30,000 美元。Bell Investment Advisors Inc 在第一季度將其在 CVS Health 的持股增加了 119.8%。Bell Investment Advisors Inc 目前擁有 455 股該藥房運營商的股票，價值 31,000 美元，在上個季度又購買了 248 股。Front Row Advisors LLC 在第二季度將其在 CVS Health 的持股增加了 436.5%。Front Row Advisors LLC 目前擁有 456 股該藥房運營商的股票，價值 31,000 美元，在上個季度又購買了 371 股。最後，Roxbury Financial LLC 在第二季度將其在 CVS Health 的持股增加了 78.3%。Roxbury Financial LLC 目前擁有 460 股該藥房運營商的股票，價值 32,000 美元，在此期間又購買了 202 股。當前 80.66% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><p>A number of brokerages recently issued reports on CVS. The Goldman Sachs Group increased their price objective on CVS Health from $93.00 to $95.00 and gave the stock a &#34;buy&#34; rating in a report on Wednesday, December 10th. Truist Financial set a $100.00 price target on CVS Health in a research note on Wednesday, December 10th. Wolfe Research lifted their price objective on shares of CVS Health from $85.00 to $100.00 and gave the company an &#34;outperform&#34; rating in a research note on Monday, December 8th. Jefferies Financial Group upped their price objective on shares of CVS Health from $92.00 to $98.00 in a report on Thursday, October 30th. Finally, Zacks Research cut shares of CVS Health from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Monday, September 8th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $94.67.</p>
<div class="lb-trans"><p>多家券商最近對 CVS 發佈了報告。高盛集團將 CVS Health 的目標價從 93.00 美元上調至 95.00 美元，並在 12 月 10 日的報告中給予該股票 &#34;買入&#34; 評級。Truist Financial 在 12 月 10 日的研究報告中設定了 CVS Health 的目標價為 100.00 美元。Wolfe Research 在 12 月 8 日的研究報告中將 CVS Health 的目標價從 85.00 美元上調至 100.00 美元，並給予公司 &#34;跑贏大盤&#34; 評級。Jefferies Financial Group 在 10 月 30 日的報告中將 CVS Health 的目標價從 92.00 美元上調至 98.00 美元。最後，Zacks Research 在 9 月 8 日的研究報告中將 CVS Health 的評級從 &#34;強力買入&#34; 下調至 &#34;持有&#34;。兩位投資分析師對該股票給予了強力買入評級，二十位給予了買入評級，四位給予了持有評級。根據 MarketBeat.com 的數據，該股票目前的共識評級為 &#34;適度買入&#34;，共識目標價為 94.67 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 05/12 - 05/16</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 05/12 - 05/16</li>
</ul>
</div><p><strong>Check Out Our Latest Stock Analysis on CVS</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 CVS 股票分析</strong></p>
</div><h2>CVS Health Stock Performance</h2>
<div class="lb-trans"><h2>CVS Health 股票表現</h2>
</div><p>Shares of CVS opened at $77.70 on Friday. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $85.15. The stock has a market capitalization of $98.63 billion, a P/E ratio of 204.47, a P/E/G ratio of 0.77 and a beta of 0.48. The firm's 50 day moving average is $79.09 and its 200-day moving average is $72.43. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63.</p>
<div class="lb-trans"><p>CVS 的股票在週五開盤價為 77.70 美元。CVS Health Corporation 的 12 個月低點為 43.56 美元，12 個月高點為 85.15 美元。該股票的市值為 986.3 億美元，市盈率為 204.47，市盈增長比率為 0.77，貝塔係數為 0.48。該公司的 50 日移動平均線為 79.09 美元，200 日移動平均線為 72.43 美元。該公司的債務與股本比率為 0.83，流動比率為 0.83，速動比率為 0.63。</p>
</div><ul>
<li>Is It Time to Buy the Dip in Novo Nordisk Stock?</li>
</ul>
<div class="lb-trans"><ul>
<li>現在是購買諾和諾德股票的好時機嗎？</li>
</ul>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.24. The firm had revenue of $102.87 billion during the quarter, compared to analysts' expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm's revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period last year, the firm posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>CVS Health (NYSE:CVS - 獲取免費報告) 最近在 10 月 29 日發佈了其財報。該藥房運營商報告本季度每股收益為 1.60 美元，超過分析師一致預期的 1.36 美元，超出 0.24 美元。該公司本季度的收入為 1,028.7 億美元，而分析師預期為 988.5 億美元。CVS Health 的淨利潤率為 0.12%，股本回報率為 11.45%。該公司本季度的收入同比增長 7.8%。去年同期，該公司每股收益為 1.09 美元。CVS Health 已將其 2025 財年的指導目標設定為 6.550-6.650 每股收益。股票研究分析師預計 CVS Health Corporation 本財年將發佈 5.89 每股收益。</p>
</div><h2>CVS Health Profile</h2>
<div class="lb-trans"><h2>CVS Health 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.</p>
<div class="lb-trans"><p>CVS Health Corporation 是一家多元化的醫療保健公司，運營着一個大型零售藥房網絡、藥房福利管理服務和醫療保健解決方案。公司總部位於羅德島州的伍恩索克特，追溯其根源至 1960 年代初期，已發展成為一個綜合的處方藥、非處方產品、臨牀服務和健康保險產品的提供者。其運營模式結合了零售藥房和店內診所以及更廣泛的藥房和健康計劃能力。</p>
</div><p>Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.</p>
<div class="lb-trans"><p>主要業務活動包括 CVS 藥房零售運營、MinuteClinic 診所和提供擴展臨牀服務的 HealthHUB 位置。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>Mastering Discipline: Overcoming Emotional Challenges In Trading</li>
<li>These 3 Banks Are Rallying Into Year-End, But Will It Continue?</li>
<li>How to Know if a Stock Pays Dividends and When They Are Paid Out</li>
<li>3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&amp;P 500</li>
<li>How to Calculate Return on Investment (ROI)</li>
<li>This ETF Caught a Major Tailwind After the Fed’s Rate Cut</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票超過 CVS Health</li>
<li>精通紀律：克服交易中的情緒挑戰</li>
<li>這三家銀行在年末反彈，但這種趨勢會持續嗎？</li>
<li>如何知道一隻股票是否支付股息以及何時支付</li>
<li>三隻飆升的股票剛剛獲得標準普爾 500 的最終批准</li>
<li>如何計算投資回報率 (ROI)</li>
<li>該 ETF 在美聯儲降息後獲得了重大順風</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 CVS Health 嗎？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 CVS Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而 CVS Health 並不在名單上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 CVS Health 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

ABLE Financial Group LLC 購買了 41,227 股西維斯健康公司（CVS Health Corporation）的股票